> Asthma

> Chronic Obstructive Pulmonary Disease (COPD)

> Inflammatory Bowel Disease (IBD)

> Intestinal Infections

> COVID-19

> Influenza

> Human Rhinovirus (HRV)

> Respiratory Syncytial Virus (RSV)

> Customized Assays and Model Development

> Antiviral Activity 

> Anti-inflammatory Effects

> Anti-fibrotic Properties

> Organoid-based Neutralization Assay

> 7-day Dose-range Finding

> 14-day Acute Toxicity

> 28-day Chronic Toxicity

> Customized Assays and Model Development

> Please Inquire

> Please Inquire

> Drug Screening & Efficacy Testing

> Toxicology & Safety Profiling

> Disease Modeling & Personalized Medicine

Personalized Medicine: Enable donor-specific testing and stratified therapeutic development.

Human Relevant: Mimic the structure and function, offering more predictive data than traditional 2D cell lines or animal models.

Disease Specific: Precise Modeling of conditions, e.g., Cancer, COPD, and Viral Infections.

Ethical & Regulatory: Reduces animal use in line with global regulations.

We offer a curated repository of high-quality normal and cancer organoids derived from diverse, well-characterized tissue sources. Our biobank supports a wide range of applications in drug screening, toxicity testing, and disease modeling, with customizable options by donor profile, disease state, and tissue origin.

Available in both ready-to-use and cryopreserved formats, the biobank enables scalable access to physiologically relevant models for early-stage discovery, translational research, and personalized therapeutic development.